Composition

Each vial contains 300 mg of Ocrelizumab in 10 mL at a concentration of 30 mg/mL. The final medicinal product concentration after dilution is approximately 1.2 mg/mL. Ocrelizumab is a humanised monoclonal antibody produced in Chinese Hamster Ovary cells by recombinant DNA technology  

ATC Code

L04AA36  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

10 mL x 1’s (in vial)  

Product Description

Concentrate for solution for infusion. Clear to slightly opalescent, and colourless to pale brown solution

Manufacturer Name

Roche Diagnostics GmbH

Manufacturer Country

GERMANY  

Approval Date

2022-05-24  

Expiry Date

2027-05-23